Kubota Pharmaceutical Holdings Co., Ltd.
JPX: 4596.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ryo Kubota
- Employees
- 19
- Headquarters
- Tokyo, Japan
- IPO year
- 2016
- Market cap
- ¥5.7B
- Website
- https://www.kubotaholdings.co.jp
Loading 4596…
Loading profile data…Frequently asked questions about 4596
What does Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) do?
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also develop...
Where does 4596.T trade?
Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) trades on the Tokyo Stock Exchange.
What sector is 4596.T in?
Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kubota Pharmaceutical Holdings Co., Ltd.?
Ryo Kubota is the chief executive officer of Kubota Pharmaceutical Holdings Co., Ltd. (4596.T).
Where is Kubota Pharmaceutical Holdings Co., Ltd. headquartered?
Kubota Pharmaceutical Holdings Co., Ltd. is headquartered in Japan.
Does 4596.T pay a dividend?
Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4596.T go public?
Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) completed its initial public offering in 2016.